Literature DB >> 14667472

Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans.

K Walton1, J L C M Dorne, A G Renwick.   

Abstract

An uncertainty factor of 100 is used to derive health-based guidance values for human intakes of chemicals based on data from studies in animals. The 100-fold factor comprises 10-fold factors for species differences and for interindividual differences in response. Each 10-fold factor can be subdivided into toxicokinetic and toxicodynamic aspects with a 4.0-fold factor to allow for kinetic differences between test species and humans. The current work determined the extent of interspecies differences in the internal dose (toxicokinetics) of compounds which are eliminated primarily by renal excretion in humans. An analysis of the published data showed that renal excretion was also the main route of elimination in the test species for most of the identified probe substrates. Interspecies differences were apparent for both the mechanism of renal excretion (glomerular filtration, tubular secretion and/or reabsorption) and the extent of plasma protein binding, both of which may affect renal clearance and therefore the magnitude of species differences in the internal dose. For compounds which are eliminated unchanged by both humans and the test species, the average differences in the internal doses between humans and animals were 1.6 for dogs, 3.3 for rabbits, 5.2 for rats and 13 for mice. This suggests that for renal excretion, the differences between humans and the rat and especially the mouse may exceed the 4.0-fold default factor for toxicokinetics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14667472     DOI: 10.1016/j.fct.2003.09.001

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  10 in total

1.  Effect of Nanoparticle Synthetic Conditions on Ligand Coating Integrity and Subsequent Nano-Biointeractions.

Authors:  Jessica C Hsu; Yu Du; Arjun Sengupta; Yuxi C Dong; Katherine J Mossburg; Mathilde Bouché; Andrew D A Maidment; Aalim M Weljie; David P Cormode
Journal:  ACS Appl Mater Interfaces       Date:  2021-11-30       Impact factor: 9.229

2.  Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effective.

Authors:  Derek Overstreet; Alex McLaren; Francis Calara; Brent Vernon; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2014-09-17       Impact factor: 4.176

3.  Transport and dynamics of toxic pollutants in the natural environment and their effect on human health: research gaps and challenge.

Authors:  Andrew Hursthouse; George Kowalczyk
Journal:  Environ Geochem Health       Date:  2008-11-11       Impact factor: 4.609

4.  Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.

Authors:  Frances Widjaja; Sebastiaan Wesseling; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2021-10-20       Impact factor: 5.153

5.  Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein.

Authors:  Lasse Reimer; Caroline Haikal; Hjalte Gram; Vasileios Theologidis; Gergo Kovacs; Harm Ruesink; Andreas Baun; Janni Nielsen; Daniel Erik Otzen; Jia-Yi Li; Poul Henning Jensen
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

6.  Use of Physiologically Based Kinetic Modeling-Facilitated Reverse Dosimetry to Predict In Vivo Acute Toxicity of Tetrodotoxin in Rodents.

Authors:  Annelies Noorlander; Mengying Zhang; Bennard van Ravenzwaay; Ivonne M C M Rietjens
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

Review 7.  Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.

Authors:  Hifza Ahmed; Felix Bergmann; Markus Zeitlinger
Journal:  Antibiotics (Basel)       Date:  2022-07-08

8.  In vivo evaluation of temperature-responsive antimicrobial-loaded PNIPAAm hydrogels for prevention of surgical site infection.

Authors:  John M Heffernan; Derek J Overstreet; Brent L Vernon; Ryan Y McLemore; Tamas Nagy; Rex C Moore; Vajra S Badha; Erin P Childers; Michael B Nguyen; Daniel D Gentry; Francis M Calara; W Brian Saunders; Tim Feltis; Alex C McLaren
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2021-06-15       Impact factor: 3.368

Review 9.  Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.

Authors:  Nadia O Bamfo; Chelsea Hosey-Cojocari; Leslie Z Benet; Connie M Remsberg
Journal:  Pharm Res       Date:  2021-07-12       Impact factor: 4.580

Review 10.  Dispelling urban myths about default uncertainty factors in chemical risk assessment--sufficient protection against mixture effects?

Authors:  Olwenn V Martin; Scholze Martin; Andreas Kortenkamp
Journal:  Environ Health       Date:  2013-07-01       Impact factor: 5.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.